3.Does the Risk of Esophageal Adenocarcinoma Increase as the Length of Barrett's Esophagus Becomes Long?.
The Korean Journal of Gastroenterology 2016;67(6):344-346
No abstract available.
Adenocarcinoma*
;
Barrett Esophagus*
4.Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus.
Journal of Neurogastroenterology and Motility 2015;21(2):288-289
No abstract available.
Adenocarcinoma*
;
Barrett Esophagus*
;
Humans
5.A Case of Recurrence after Endoscopic Submucosal Dissection of Esophageal Adenocarcinoma Arising from Barrett's Esophagus.
Hae Young JUNG ; Young Eun JOO ; Sung Bum CHO ; Joon Il HWANG ; Seung Keun KIM ; Wan Sik LEE ; Hyen Soo KIM ; Sung Kyu CHOI
Korean Journal of Gastrointestinal Endoscopy 2009;38(2):80-84
Surgery is the primary treatment for adenocarcinoma arising from Barrett's esophagus. However, in order to avoid the high risk of complications of surgical resection, many physicians try various endoscopic treatments in cases of early adenocarcinoma and high-grade dysplasia of Barrett's esophagus. Endoscopic submucosal dissection (ESD) is a recently highlighted technique because of its high rate of en bloc resection, but there is controversy about ESD because of the uncertain long-term effect. There is a high risk of local recurrence after endoscopic treatments especially in a long-segment Barrett's esophagus, but there are no reports about this in Korea. This case we report on shows that the early adenocarcinoma arising from a long-segment Barrett's esophagus was curatively removed by ESD, but recurred high-grade dysplasia was detected on the remnant Barrett's esophagus after one year. We report here on a case of recurred esophageal malignancy after successful endoscopic resection of adenocarcinoma from a Barrett's esophagus.
Adenocarcinoma
;
Barrett Esophagus
;
Korea
;
Recurrence
6.Quality Indicators in Barrett's Esophagus: Time to Change the Status Quo.
Clinical Endoscopy 2018;51(4):344-351
The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators. In response, several gastrointestinal societies have established quality indicators specific to Barrett's esophagus, which serve to create thresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistently demonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy and obtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovative interventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett's esophagus.
Barrett Esophagus*
;
Biopsy
;
Endoscopy
;
Humans
8.Does Bile Reflux Influence the Progression of Barrett's Esophagus to Adenocarcinoma? (Gastroenterology 2013;145:1300-1311).
Tatsuhiro MASAOKA ; Hidekazu SUZUKI
Journal of Neurogastroenterology and Motility 2014;20(1):124-126
No abstract available.
Adenocarcinoma*
;
Barrett Esophagus*
;
Bile Reflux*
;
Bile*
9.Barrett's Esophagus-With Emphasis on Endoscopic Disgnosis.
Korean Journal of Gastrointestinal Endoscopy 2009;39(4):185-198
Barrett's esophagus is a metaplastic change of the esophageal mucosa, such that the normal squamous epithelium is replaced by specialized columnar epithelium. During the last decades, there has been a significant change in the definition, endoscopic diagnosis, pathologic diagnosis, surveillance and management of Barrett's esophagus. Because of the rising prevalence of gastroesophgeal reflux disease in Korea, problems related to Barrett's esophagus are expected to be much more common in the near future. In this review, methods of endoscopic diagnosis of Barrett's esophagus are discussed in detail. Management strategies in the context of Korean epidemiology are also suggested.
Barrett Esophagus
;
Epithelium
;
Korea
;
Mucous Membrane
;
Prevalence
Result Analysis
Print
Save
E-mail